Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmozyme for Chronic Rhinosinusitis in Cystic Fibrosis
NCT00265434Phase 3Completed
- Sponsor
- Friedrich Schiller University Jena
- Start
- Dec 2005
- Primary completion
- May 2006
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dornase alfa in chronic rhinosinusitis (CRS) (2 arms), sponsored by Friedrich Schiller University Jena. Primary endpoint: Sino-Nasal Outcome Test-20 at 2 years. Started Dec 2005; status: completed.
02
Drugs
dornase alfa
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT00265434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265434.